| Bioactivity | α-Glucosidase-IN-22 (compound 7i), a benzimidazole, is a potent α-glucosidase inhibitor with an IC50 of 0.64 μM. α-Glucosidase-IN-22 is a potent anti-diabetic agent and has the potential for type 2 diabetes mellitus (T2DM) research[1]. |
| Name | α-Glucosidase-IN-22 |
| CAS | 2870693-28-8 |
| Formula | C14H11N3O2S |
| Molar Mass | 285.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sardar Ali, et al. Novel 5-(Arylideneamino)-1 H-Benzo[ d]imidazole-2-thiols as Potent Anti-Diabetic Agents: Synthesis, In Vitro α-Glucosidase Inhibition, and Molecular Docking Studies. ACS Omega. 2022 Nov 23;7(48):43468-43479. |
α-Glucosidase-IN-22
CAS: 2870693-28-8 F: C14H11N3O2S W: 285.32
α-Glucosidase-IN-22 (compound 7i), a benzimidazole, is a potent α-glucosidase inhibitor with an IC50 of 0.64 μM. α-G
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.